Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional, Open-label, Prospective Study to Assess the Effectiveness of BDP/FF/G Fixed Triple Inhalation Powder on Symptom Scores in Moderate to Severe COPD Patients, Uncontrolled With Inhaled Dual Therapies (LABA/LAMA or ICS/LABA)

NCT05743608 is registered in ClinicalTrials.gov with Chiesi Hungary Ltd. as lead sponsor.

NCT NCT05743608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05743608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional, Open-label, Prospective Study to Assess the Effectiveness of BDP/FF/G Fixed Triple Inhalation Powder on Symptom Scores in Moderate to Severe COPD Patients, Uncontrolled With Inhaled Dual Therapies (LABA/LAMA or ICS/LABA)
Lead sponsor
Chiesi Hungary Ltd.
Phase
Observational
Overall status
Completed
Start date
March 29, 2023
Completion date
May 5, 2025
Enrollment
1,336 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

copd